Advanced Search
Article Contents
ABOUT THIS ARTICLE
The Innovation Drug Discovery > 2026 Vol. 1 > No. 1 > 100004
Next Article Previous Article
COMMENTARY   Open Access     Cite

Catalytic radiopharmaceuticals unlock immune memory by rewiring tumor metabolism

  • 1.

    College of Life Sciences, Longyan University, Longyan 364000, China

  • 2.

    Institute of Chemistry, University of Silesia in Katowice, Szkolna 9, 40-006 Katowice, Poland

  • 3.

    These authors contributed equally

More Information
The Innovation Drug Discovery  1(1),  https://doi.org/10.59717/j.xinn-drugdisc.2026.100004  |  Cite this article
    • FullText(HTML)
  • 加载中
    • REFERENCES
  • [1] Yang M.-D., Zhu C.-Y., Yang G., et al. (2025). Camouflaged membrane-bridged radionuclide/Mn single-atom enzymes target lipid metabolism disruption to evoke antitumor immunity. Military Medical Research 12:59. DOI:10.1186/s40779-025-00647-7

    View in Article CrossRef Google Scholar

    [2] Sgouros G., Bodei L., McDevitt M. R., et al. (2020). Radiopharmaceutical therapy in cancer: clinical advances and challenges. Nature Reviews Drug Discovery 19:589−608. DOI:10.1038/s41573-020-0073-9

    View in Article CrossRef Google Scholar

    [3] Guo S., Yao Y., Tang Y., et al. (2023). Radiation-induced tumor immune microenvironments and potential targets for combination therapy. Signal Transduction and Targeted Therapy 8:205. DOI:10.1038/s41392-023-01462-z

    View in Article CrossRef Google Scholar

    [4] Quazi T. H. S. (2023). Iron oxide nanoparticles in magnetic drug targeting and ferroptosis-based cancer therapy. Medical Review 3:444−447. DOI:10.1515/mr-2023-0029

    View in Article CrossRef Google Scholar

    [5] Pan H., Yang S., Gao L., et al. (2024). At the crossroad of nanotechnology and cancer cell membrane coating: Expanding horizons with engineered nanoplatforms for advanced cancer therapy harnessing homologous tumor targeting. Coordination Chemistry Reviews 506:215712. DOI:10.1016/j.ccr.2024.215712

    View in Article CrossRef Google Scholar

    • Cited by

  • Cite this article:

    Pan H., Yang S., Zheng X., et al. (2026). Catalytic radiopharmaceuticals unlock immune memory by rewiring tumor metabolism. The Innovation Drug Discovery 1:100004. https://doi.org/10.59717/j.xinn-drugdisc.2026.100004
    Pan H., Yang S., Zheng X., et al. (2026). Catalytic radiopharmaceuticals unlock immune memory by rewiring tumor metabolism. The Innovation Drug Discovery 1:100004. https://doi.org/10.59717/j.xinn-drugdisc.2026.100004

Welcome!

To request copyright permission to republish or share portions of our works, please visit Copyright Clearance Center's (CCC) Marketplace website at marketplace.copyright.com.

PDF
Figures(1)    

Share

  • Share the QR code with wechat scanning code to friends and circle of friends.

Article Metrics

Article views(611) PDF downloads(267)

Relative Articles

Cited by

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return

    {{newsColumn.name}}

    {{newsColumn.name}}

    Stay connected

    {{newsColumn.name}}

    Website copyright © Innovation Press. Published articles are licensed under CC BY with copyright retained by the authors.